Qiagen (QGEN) Competitors $48.59 +0.38 (+0.79%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$48.53 -0.06 (-0.12%) As of 07:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock QGEN vs. ARGX, ONC, BNTX, TEVA, SMMT, ITCI, GMAB, RDY, ASND, and VTRSShould you be buying Qiagen stock or one of its competitors? The main competitors of Qiagen include argenex (ARGX), BeOne Medicines (ONC), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), and Viatris (VTRS). These companies are all part of the "pharmaceutical products" industry. Qiagen vs. Its Competitors argenex BeOne Medicines BioNTech Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Ascendis Pharma A/S Viatris Qiagen (NYSE:QGEN) and argenex (NASDAQ:ARGX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership. Which has better earnings and valuation, QGEN or ARGX? argenex has higher revenue and earnings than Qiagen. argenex is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.98B5.46$83.59M$0.40121.48argenex$2.25B14.78$833.04M$16.2133.63 Which has more volatility & risk, QGEN or ARGX? Qiagen has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, argenex has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Do analysts recommend QGEN or ARGX? Qiagen currently has a consensus target price of $49.40, indicating a potential upside of 1.67%. argenex has a consensus target price of $729.93, indicating a potential upside of 33.91%. Given argenex's stronger consensus rating and higher possible upside, analysts plainly believe argenex is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30argenex 0 Sell rating(s) 1 Hold rating(s) 17 Buy rating(s) 2 Strong Buy rating(s) 3.05 Do insiders & institutionals have more ownership in QGEN or ARGX? 70.0% of Qiagen shares are held by institutional investors. Comparatively, 60.3% of argenex shares are held by institutional investors. 9.0% of Qiagen shares are held by insiders. Comparatively, 2.4% of argenex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is QGEN or ARGX more profitable? argenex has a net margin of 40.20% compared to Qiagen's net margin of 4.68%. argenex's return on equity of 16.15% beat Qiagen's return on equity.Company Net Margins Return on Equity Return on Assets Qiagen4.68% 14.61% 8.80% argenex 40.20%16.15%14.33% Does the media prefer QGEN or ARGX? In the previous week, argenex had 8 more articles in the media than Qiagen. MarketBeat recorded 19 mentions for argenex and 11 mentions for Qiagen. Qiagen's average media sentiment score of 0.78 beat argenex's score of 0.46 indicating that Qiagen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive argenex 4 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Summaryargenex beats Qiagen on 12 of the 17 factors compared between the two stocks. Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QGEN vs. The Competition Export to ExcelMetricQiagenMED IndustryMedical SectorNYSE ExchangeMarket Cap$10.72B$2.88B$5.54B$20.53BDividend YieldN/A2.64%5.39%3.77%P/E Ratio121.8321.3126.2327.85Price / Sales5.46278.47413.2337.49Price / Cash15.0441.4736.1321.91Price / Book3.037.518.044.55Net Income$83.59M-$55.05M$3.15B$984.95M7 Day Performance1.09%2.07%1.44%2.31%1 Month Performance7.32%4.84%3.62%4.85%1 Year Performance23.16%5.37%34.68%13.81% Qiagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QGENQiagen3.7836 of 5 stars$48.59+0.8%$49.40+1.7%+22.8%$10.72B$1.98B121.835,765Dividend AnnouncementARGXargenex4.3177 of 5 stars$540.76-0.3%$709.18+31.1%+25.2%$33.02B$2.25B33.361,599Analyst ForecastONCBeOne Medicines3.5482 of 5 stars$257.51+4.2%$319.00+23.9%N/A$28.22B$3.81B-69.2211,000Gap UpBNTXBioNTech2.5077 of 5 stars$103.01-3.3%$137.86+33.8%+37.5%$24.76B$2.98B-30.306,772TEVATeva Pharmaceutical Industries4.0869 of 5 stars$16.96+0.1%$24.44+44.1%+3.0%$19.45B$16.54B-14.7536,830SMMTSummit Therapeutics2.4753 of 5 stars$20.39-0.8%$35.09+72.1%+200.0%$15.14B$700K-59.97110Analyst ForecastITCIIntra-Cellular Therapies0.9247 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560GMABGenmab A/S3.8892 of 5 stars$20.68-2.3%$39.17+89.4%-17.9%$13.26B$3.12B11.752,682High Trading VolumeRDYDr. Reddy's Laboratories2.8228 of 5 stars$15.31+0.5%$16.95+10.7%-2.3%$12.78B$3.81B23.2027,811ASNDAscendis Pharma A/S3.5796 of 5 stars$175.78-0.6%$220.67+25.5%+27.0%$10.75B$393.54M-27.991,017Positive NewsVTRSViatris3.0627 of 5 stars$8.85-0.2%$10.40+17.5%-10.5%$10.39B$14.74B-2.7932,000 Related Companies and Tools Related Companies ARGX Alternatives ONC Alternatives BNTX Alternatives TEVA Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives ASND Alternatives VTRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:QGEN) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
